Several key science payloads will be delivered to the International Space Station (ISS). Among these is a biomedical investigation that focuses on the mechanisms behind neuroinflammation, a condition associated with neurodegenerative diseases like Alzheimer’s, Parkinson’s, and multiple sclerosis. This study will utilize 3D brain models derived from patient stem cells to explore potential treatments​.

Additionally, the mission will carry the Multi-Resolution Scanner (MRS), which will use the Astrobee autonomous robot aboard the ISS to create detailed 3D maps of the space environment. This technology could have significant applications in future space exploration, allowing for automated assessments of spacecraft damage and other remote monitoring tasks.

These research initiatives are part of NASA's ongoing efforts to leverage space-based research for both Earth-based health advancements and the development of future spaceflight technologies.

The launch date is currently targeted for Wednesday, October 30, 2024 at 4:50 AM (UTC).